Breaking News
Sort by:
Date
Top Post
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
Haemonetics Appoints James D'Arecca Chief Financial Officer
Haemonetics Corporation (NYSE: HAE) today announced that James C. D’Arecca will join the Company as Executive […]
Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to […]
- Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board Read more
- Toragen Announces Appointment of Chief Scientific Officer Read more
- First Citizens Bank Provides $31.2 Million for Acquisition of Cancer Treatment Center in Columbia, South Carolina Read more
- Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics Read more
- ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more